Aggregatibacter actinomycetemcomitans infection enhances apoptosis in vivo through a caspase-3-dependent mechanism in experimental periodontitis

Infection and Immunity

Volumn 80, Issue 6, 2012, Pages 2247-2256

  Kang, Jun ^a,b   Bezerra, Beatriz de Brito ^c   Pacios, Sandra ^b,e   Andriankaja, Oelisoa ^b   Li, Yu ^d   Tsiagbe, Vincent ^d   Schreiner, Helen ^d   Fine, Daniel H ^d   Graves, Dana T ^a,b  

^a PEKING UNIVERSITY SCHOOL AND HOSPITAL OF STOMATOLOGY   (China)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF CAMPINAS   (Brazil)

^d RUTGERS SCHOOL OF DENTAL MEDICINE   (United States)

^e UNIVERSITAT INTERNACIONAL DE CATALUNYA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 3 INHIBITOR; TUMOR NECROSIS FACTOR ALPHA; ANTIINFECTIVE AGENT; BACTERIUM ANTIBODY; CASP3 PROTEIN, RAT; IMMUNOGLOBULIN G;

AGGREGATIBACTER ACTINOMYCETEMCOMITANS; AGGREGATIBACTER ACTINOMYCETEMCOMITANS INFECTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONNECTIVE TISSUE; CONTROLLED STUDY; DIABETES MELLITUS; EPITHELIUM; EXPERIMENTAL PERIODONTITIS; GINGIVA; IMMUNOHISTOCHEMISTRY; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NICK END LABELING; NONHUMAN; OSTEOLYSIS; PASTEURELLACEAE INFECTION; PERIODONTITIS; PRIORITY JOURNAL; RAT; ACTINOBACILLUS INFECTION; ANIMAL; BACTERIUM ADHERENCE; BLOOD; DRUG ANTAGONISM; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; METABOLISM; PATHOLOGY; WISTAR RAT;

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; ACTINOBACILLUS INFECTIONS; ANIMALS; ANTI-BACTERIAL AGENTS; ANTIBODIES, BACTERIAL; APOPTOSIS; BACTERIAL ADHESION; CASPASE 3; DIABETES MELLITUS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; IMMUNOGLOBULIN G; PERIODONTITIS; RATS; RATS, WISTAR;

EID: 85047688419     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.06371-11     Document Type: Article

References (43)

1. Alaoui-El-Azher M, et al. 2010. Role of the ATM-checkpoint kinase 2 pathway in CDT-mediated apoptosis of gingival epithelial cells. PLoS One 5:e11714.
2. Alikhani M, et al. 2003. Lipopolysaccharides indirectly stimulate apoptosis and global induction of apoptotic genes in fibroblasts. J. Biol. Chem. 278:52901-52908.
3. Armitage GC, Cullinan MP. 2010. Comparison of the clinical features of chronic and aggressive periodontitis. Periodontol. 2000 53:12-27.
4. Boch JA, Wara-aswapati N, Auron PE. 2001. Interleukin 1 signal transduction: current concepts and relevance to periodontitis. J. Dent. Res. 80:400-407.
5. Christersson LA. 1993. Actinobacillus actinomycetemcomitans and localized juvenile periodontitis: clinical, microbiologic, and histologic studies. Swed. Dent. J. Suppl. 90:1- 46.
6. Dickinson BC, et al. 2011. Interaction of oral bacteria with gingival epithelial cell multilayers. Mol. Oral Microbiol. 26:210-220.
7. Fine DH, Furgang D. 2002. Lactoferrin iron levels affect attachment of Actinobacillus actinomycetemcomitans to buccal epithelial cells. J. Periodontol. 73:616-623.
8. Fine DH, et al. 2001. Colonization and persistence of rough and smooth colony variants of Actinobacillus actinomycetemcomitans in the mouths of rats. Arch. Oral Biol. 46:1065-1078.
9. Fine DH, et al. 2007. Aggregatibacter actinomycetemcomitans and its relationship to initiation of localized aggressive periodontitis: longitudinal cohort study of initially healthy adolescents. J. Clin. Microbiol. 45:3859- 3869.
10. Goncharoff P, Figurski DH, Stevens RH, Fine DH. 1993. Identification of Actinobacillus actinomycetemcomitans: polymerase chain reaction amplification of lktA-specific sequences. Oral Microbiol. Immunol. 8:105- 110.
11. Graves D, et al. 2001. Tumor necrosis factor modulates fibroblast apoptosis, PMN recruitment, and osteoclast formation in response to P. gingivalis infection. J. Dent. Res. 80:1875-1879.
12. Graves DT, Kayal RA. 2008. Diabetic complications and dysregulated innate immunity. Front. Biosci. 13:1227-1239.
13. Graves DT, Li J, Cochran DL. 2011. Inflammation and uncoupling as mechanisms of periodontal bone loss. J. Dent. Res. 90:143-153.
14. Graves DT, Liu R, Oates TW. 2007. Diabetes-enhanced inflammation and apoptosis: impact on periodontal pathosis. Periodontol. 2000 45: 128-137.
15. Graves DT, et al. 2005. Inflammation is more persistent in type 1 diabetic mice. J. Dent. Res. 84:324 -328.
16. Haubek D, et al. 2008. Risk of aggressive periodontitis in adolescent carriers of the JP2 clone of Aggregatibacter (Actinobacillus) actinomycetemcomitans in Morocco: a prospective longitudinal cohort study. Lancet 371: 237-242.
17. He H, et al. 2004. Diabetes causes decreased osteoclastogenesis, reduced bone formation, and enhanced apoptosis of osteoblastic cells in bacteria stimulated bone loss. Endocrinology 145:447- 452.
18. Heller D, et al. 2011. Impact of systemic antimicrobials combined with anti-infective mechanical debridement on the microbiota of generalized aggressive periodontitis: a 6-month RCT. J. Clin. Periodontol. 38:355-364.
19. Jinadasa RN, Bloom SE, Weiss RS, Duhamel GE. 2011. Cytolethal distending toxin: a conserved bacterial genotoxin that blocks cell cycle progression, leading to apoptosis of a broad range of mammalian cell lineages. Microbiology 157:1851-1875.
20. Kachlany SC. 2010. Aggregatibacter actinomycetemcomitans leukotoxin: from threat to therapy. J. Dent. Res. 89:561-570.
21. Kasai H, Yamamoto K, Koseki T, Yokota M, Nishihara T. 2004. Involvement of caspase activation through release of cytochrome c from mitochondria in apoptotic cell death of macrophages infected with Actinobacillus actinomycetemcomitans. FEMS Microbiol. Lett. 233:29 -35.
22. Kato S, et al. 1995. Evidence for apoptosis of murine macrophages by Actinobacillus actinomycetemcomitans infection. Infect. Immun. 63:3914- 3919.
23. Kato S, Sugimura N, Nakashima K, Nishihara T, Kowashi Y. 2005. Actinobacillus actinomycetemcomitans induces apoptosis in human monocytic THP-1 cells. J. Med. Microbiol. 54:293-298.
24. Kirkwood KL, Cirelli JA, Rogers JE, Giannobile WV. 2007. Novel host response therapeutic approaches to treat periodontal diseases. Periodontol. 2000 43:294 -315.
25. Lalla E, et al. 2000. Blockade of RAGE suppresses periodontitis-associated bone loss in diabetic mice. J. Clin. Invest. 105:1117-1124.
26. Lalla E, Papapanou PN. 2011. Diabetes mellitus and periodontitis: a tale of two common interrelated diseases. Nat. Rev. Endocrinol. 7:738 -748.
27. Lamster IB, Lalla E, Borgnakke WS, Taylor GW. 2008. The relationship between oral health and diabetes mellitus. J. Am. Dent. Assoc. 139(Suppl): 19S-24S.
28. Li Y, et al. 2010. Adaptive immune response in osteoclastic bone resorption induced by orally administered Aggregatibacter actinomycetemcomitans in a rat model of periodontal disease. Mol. Oral Microbiol. 25:275-292.
29. Liu R, et al. 2006. Diabetes enhances periodontal bone loss through enhanced resorption and diminished bone formation. J. Dent. Res. 85: 510-514.
30. Mahamed DA, et al. 2005. G(-) anaerobes-reactive CD4+ T cells trigger RANKL-mediated enhanced alveolar bone loss in diabetic NOD mice. Diabetes 54:1477-1486.
31. Mandell RL, Socransky SS. 1988. Microbiological and clinical effects of surgery plus doxycycline on juvenile periodontitis. J. Periodontol. 59:373- 379.
32. Mogi M, et al. 1999. Interleukin 1 beta, interleukin 6, beta 2-microglobulin, and transforming growth factor-alpha in gingival crevicular fluid from human periodontal disease. Arch. Oral Biol. 44:535-539.
33. Naguib G, Al-Mashat H, Desta T, Graves D. 2004. Diabetes prolongs the inflammatory response to a bacterial stimulus through cytokine dysregulation. J. Invest. Dermatol. 123:87-92.
34. Nikolajczyk BS, Jagannathan-Bogdan M, Shin H, Gyurko R. 2011. State of the union between metabolism and the immune system in type 2 diabetes. Genes Immun. 12:239 -250.
35. Ohara M, Miyauchi M, Tsuruda K, Takata T, Sugai M. 2011. Topical application of Aggregatibacter actinomycetemcomitans cytolethal distending toxin induces cell cycle arrest in the rat gingival epithelium in vivo. J. Periodontal Res. 46:389 -395.
36. Pihlstrom BL, Michalowicz BS, Johnson NW. 2005. Periodontal diseases. Lancet 366:1809 -1820.
37. Salvi G, et al. 1997. Monocytic TNFalpha secretion patterns in IDDM patients with periodontal diseases. J. Clin. Periodontol. 24:8 -16.
38. Schreiner H, et al. 2011. Aggregatibacter actinomycetemcomitans- induced bone loss and antibody response in three rat strains. J. Periodontol. 82:142-150.
39. Schreiner HC, et al. 2003. Tight-adherence genes of Actinobacillus actinomycetemcomitans are required for virulence in a rat model. Proc. Natl. Acad. Sci. U. S. A. 100:7295-7300.
40. Taylor G, et al. 1998. Non-insulin-dependent diabetes mellitus and alveolar bone loss progression over 2 years. J. Periodontol. 69:76-83.
41. Xajigeorgiou C, Sakellari D, Slini T, Baka A, Konstantinidis A. 2006. Clinical and microbiological effects of different antimicrobials on generalized aggressive periodontitis. J. Clin. Periodontol. 33:254 -264.
42. Yek EC, et al. 2010. Efficacy of amoxicillin and metronidazole combination for the management of generalized aggressive periodontitis. J. Periodontol. 81:964 -974.
43. Zappa U, Reinking-Zappa M, Graf H, Chase D. 1992. Cell populations associated with active probing attachment loss. J. Periodontol. 63:748-752.